[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2021) Cancer Statistics, 2021. CA, 71, 7-33.
https://doi.org/10.3322/caac.21654
|
[2]
|
Rahib, L., Smith, B.D., Aizenberg, R., Rosenzweig, A.B., Fleshman, J.M. and Matrisian, L.M. (2014) Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver and Pancreas Cancers in the United States. Cancer Research, 74, 2913-2921. https://doi.org/10.1158/0008-5472.CAN-14-0155
|
[3]
|
Balachandran, V.P., Beatty, G.L. and Dougan, S.K. (2019) Broadening the Impact of Immunotherapy to PancreaticCancer: Challenges and Opportunities. Gastroenterology, 156, 2056-2072. https://doi.org/10.1053/j.gastro.2018.12.038
|
[4]
|
Mizrahi, J.D., Surana, R., Valle, J.W. and Shroff, R.T. (2020) Pancreatic Cancer. The Lancet, 395, 2008-2020.
https://doi.org/10.1016/S0140-6736(20)30974-0
|
[5]
|
Tsvetkov, P., Coy, S., Petrova, B., et al. (2022) Copper In-duces Cell Death by Targeting Lipoylated TCA Cycle Proteins. Science, 375, 1254-1261. https://doi.org/10.1126/science.abf0529
|
[6]
|
Connor, A.A. and Gallinger, S. (2022) Pancreatic Cancer Evolution and Heterogeneity: Integrating Omics and Clinical data. Nature Reviews Cancer, 22, 131-142. https://doi.org/10.1038/s41568-021-00418-1
|
[7]
|
Collisson, E.A., Sadanandam, A., Olson, P., et al. (2011) Sub-types of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy. Nature Medicine, 17, 500-503. https://doi.org/10.1038/nm.2344
|
[8]
|
Bailey, P., Chang, D.K., Nones, K., et al. (2016) Genomic Analyses Identify Molecular Subtypes of Pancreatic Cancer. Nature, 531, 47-52. https://doi.org/10.1038/nature16965
|
[9]
|
Gao, Y., Shang, S., Guo, S., et al. (2021) Lnc2Cancer 3.0: An Updated Resource for Experimentally Supported lncRNA/circRNA Cancer Associations and Web Tools Based on RNA-seq and scRNA-seq Data. Nucleic Acids Research, 49, D1251-D1258. https://doi.org/10.1093/nar/gkaa1006
|
[10]
|
李宝平, 储宣宁, 庞树洋, 等. lncRNA作为胰腺癌诊断和治疗靶点的研究进展[J]. 药物生物技术, 2021, 28(4): 414-418. https://doi.org/10.19526/j.cnki.1005-8915.20210418
|
[11]
|
Cabrita, R., Lauss, M., Sanna, A., et al. (2020) Tertiary Lymphoid Structures Improve Immunotherapy and Survival in Melanoma. Nature, 577, 561-565. https://doi.org/10.1038/s41586-019-1914-8
|
[12]
|
Miguel, V., Lamas, S. and Espinosa-Diez, C. (2020) Role of Non-Coding-RNAs in Response to Environmental Stressors and Consequences on Human Health. Redox Biology, 37, Article ID: 101580.
https://doi.org/10.1016/j.redox.2020.101580
|
[13]
|
Ponting, C.P., Oliver, P.L. and Reik, W. (2009) Evolution and Functions of Long Noncoding RNAs. Cell, 136, 629-641. https://doi.org/10.1016/j.cell.2009.02.006
|
[14]
|
Tay, Y., Karreth, F.A. and Pandolfi, P.P. (2014) Aberrant ceRNA Activity Drives Lung Cancer. Cell Research, 24, 259-260. https://doi.org/10.1038/cr.2014.21
|
[15]
|
Salmena, L., Poliseno, L., Tay, Y., et al. (2011) A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?. Cell, 146, 353-358. https://doi.org/10.1016/j.cell.2011.07.014
|
[16]
|
Yildirim, E., Kirby, J.E., Brown, D.E., et al. (2013) Xist RNA Is a Potent Suppressor of Hematologic Cancer in Mice. Cell, 152, 727-742. https://doi.org/10.1016/j.cell.2013.01.034
|
[17]
|
Pang, E.J., Yang, R., Fu, X.B. and Liu, Y.-F. (2015) Overexpres-sion of Long Non-Coding RNA MALAT1 Is Correlated with Clinical Progression and Unfavorable Prognosis in Pan-creatic Cancer. Tumor Biology, 36, 2403-2407.
https://doi.org/10.1007/s13277-014-2850-8
|
[18]
|
Zhou, C., Yi, C., Yi, Y., et al. (2020) LncRNA PVT1 Promotes Gemcitabine Resistance of Pancreatic Cancer via Activating Wnt/β-Catenin and Autophagy Pathway through Modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Molecular Cancer, 19, Article No. 118. https://doi.org/10.1186/s12943-020-01237-y
|
[19]
|
杨冬梅, 王睿, 潘怡, 等. 长链非编码RNA在胰腺癌中的研究进展[J]. 药物生物技术, 2022, 29(3): 305-309.
https://doi.org/10.19526/j.cnki.1005-8915.20220316
|
[20]
|
Chen, Z., Hu, Z., Sui, Q., et al. (2022) LncRNA FAM83A-AS1 Facilitates Tumor Proliferation and the Migration via the HIF-1α/Glycolysis Axis in Lung Adenocarci-noma. International Journal of Biological Sciences, 18, 522-535.
https://doi.org/10.7150/ijbs.67556
|
[21]
|
Li, X., Zhou, S., Fan, T., et al. (2020) lncRNA DGCR 5/miR-27a-3p/BNIP3 Promotes Cell Apoptosis in Pancreatic Cancer by Regulating the p38 MAPK Pathway. Interna-tional Journal of Biological Sciences, 46, 729-739.
https://doi.org/10.3892/ijmm.2020.4632
|
[22]
|
Yao, Y., Gao, P., Chen, L., et al. (2018) Upregulated Long Non-Coding RNA SPRY4-IT1 Predicts Dismal Prognosis for Pancreatic Ductal Adenocarcinoma and Regulates Cell Proliferation and Apoptosis. Gene, 659, 52-58.
https://doi.org/10.1016/j.gene.2018.03.048
|
[23]
|
Previdi, M.C., Carotenuto, P., Zito, D., et al. (2017) Noncoding RNAs as Novel Biomarkers in Pancreatic Cancer: What Do We Know? Future Medicine, 13, 443-453. https://doi.org/10.2217/fon-2016-0253
|
[24]
|
Okada, Y., Takahashi, N., Takayama, T. and Goel, A. (2021) LAMC2 Promotes Cancer Progression and Gemcitabine Resistance through Modulation of EMT and ATP-Binding Cassette Transporters in Pancreatic Ductal Adenocarcinoma. Carcinogenesis, 42, 546-556. https://doi.org/10.1093/carcin/bgab011
|
[25]
|
Huang, W., Li, H., Yu, Q., Xiao, W. and Wang, D.O. (2022) LncRNA-Mediated DNA Methylation: An Emerging Mechanism in Cancer and beyond. Journal of Experimental & Clinical Cancer Research, 41, Article No. 100.
https://doi.org/10.1186/s13046-022-02319-z
|
[26]
|
Giulietti, M., Righetti, A., Principato, G., et al. (2018) LncRNA Co-Expression Network Analysis Reveals Novel Biomarkers for Pancreatic Cancer. Carcinogenesis, 39, 1016-1025. https://doi.org/10.1093/carcin/bgy069
|
[27]
|
Ou, Z.L., Luo, Z. and Lu, Y.B. (2019) Long Non-Coding RNA HULC as a Diagnostic and Prognostic Marker of Pancreatic Cancer. World Journal of Gastroenterology, 25, 6728-6742. https://doi.org/10.3748/wjg.v25.i46.6728
|